EFTA02278036.pdf
PDF Source (No Download)
Extracted Text (OCR)
To:
Lesley Groff(
From:
Richard Kahn
Sent
subsa
Thu
PM
.
Re:
i will mention to jee when we speak next
thanks
Richard Kahn
HBRK Associates Inc.
575 Lexington Avenue 4th Floor
New York NY 10022
tel
fax
cell
am.
On Jan 17, 2019, at 12:19 PM, Lesley Groff ‹
> wrote:
requested I forward you the below `catch up' email.
Christina Galbraith
Director of Genetic Therapies
Bioilebe LLC
<1506365439123blobjpg>
Fo
From:
To: jeevacationAomail.com <jeevacabonOornail.com>;
Sent: Wednesday, January 16, 2019, 11:22:06 PM EST
EFTA_R1_01093559
EFTA02278036
Subject: Catching Up
Dear Jeffrey
I hope you've been well. I wanted to update you on what I've been up to for the last
two years. I was also hoping to talk with you to see if I might use the
foundation's Lexington office conference room from time to time for
my work and what I could provide in exchange for that. I am &ling
Rich because I'm not sure if you still use this email?
Since working for your foundation, I continued to publish as a journalist writing
mostly about genetic vectors (Newsweek, Techonomy etc). I then set
up an LLC that provides business development for labs that have
reversed age-driven or degenerative diseases. Most of the therapies
are genetic vectors, and have to show remarkable results at the mouse
level and beyond. Regenerative medicine is a rapidly evolving field,
and one that forces the medical industry to shift their focus from
addressing symptoms of disease to fundamental evolutionary
shortfalls.
So far, I placed a genetic vector at the National Institute of Medicine in France (that
reversed glaucoma in mice using the neuroglobin gene) under formal
licence review with a publicly traded pharma group here in the US.
And I am collaborating with a lab at the University of Pittsburgh that
has reversed cirrhosis/ end stage liver disease in rats using the master
transcription gene in hepatocytes. The concept of the latter gene
vector is really intriguing in that a master transcription gene
completely restored liver function by rebalancing genetic expression
and thus proteostasis.
While I don't really need an office at this point, I do need access to a conference
room from time to time and it would be hugely helpful if I could
access the foundation's. If there was some work that I could do for
the foundation in exchange, I would be delighted to do that.
It would be wonderful to catch up with you as well.
all the best,
EFTA_R1_01093560
EFTA02278037
<1506365439123blobjpg>
<I 506365439123blobjpg><1506365439123blobjpg>
EFTA_R1_01093561
EFTA02278038
Document Preview
PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
Extracted Information
Document Details
| Filename | EFTA02278036.pdf |
| File Size | 154.9 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 2,608 characters |
| Indexed | 2026-02-12T13:12:58.034305 |